CNCE

Concert Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD8.37

+0.00 (+0.00%)

CEO

Roger D. Tung

IPO Date

2014-02-13

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Open

$8.38

Prev. Close

$8.37

Day Low

$8.35

Day High

$8.55

52W Low

$2.72

52W High

$8.55

News SentimentNeutral

Articles

Avg Positive

9.7%

Avg Negative

11.7%

Avg Neutral

78.7%

News Feed

Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q2 2021 Results - Earnings Call Transcript

Concert Pharmaceuticals Presents Update on CTP-543 Long-Term Extension Study in Alopecia Areata During 2nd JAK Inhibitors Drug Development Summit

Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q1 2021 Results - Earnings Call Transcript